Dec 5 (Reuters) - Bio-UV Group SA ALTUV.PA :
* SALES FOR THE SECOND HALF OF 2023 NOW EXPECTED TO BE DOWN
ON THE
FIRST HALF, WITH FULL-YEAR SALES FOR 2023 TARGETED AT BETWEEN
EUR42M AND EUR43M
* TIGHT OPERATIONAL MANAGEMENT: DOUBLE-DIGIT EBITDA MARGIN
TO BE
MAINTAINED BY 2023
* CONFIRMATION OF STRONG FREE CASH FLOW GENERATION IN 2023
AND
CONTINUED REDUCTION IN THE GROUP'S FINANCIAL DEBT
Source text for Eikon: ID:nACT83162
Further company coverage: ALTUV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))